Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Dumas

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Opinion in Drug Discovery & Development|March 13, 2003
Protein kinase inhibitors from the urea classJacques Dumas
Expert Opinion on Therapeutic Patents|February 10, 2010
VEGF receptor kinase inhibitors: phthalazines, anthranilamides and related structuresJacques Dumas, Julie A Dixon
Medecine Sciences : M/S|January 7, 2020
[Developability assessment]Jacques Dumas, Sylvain Huille, Catherine Prades
Chaos (Woodbury, N.Y.)|February 24, 2026
Quantification of the cascading tipping probability from the AMOC to the Amazon rainforest with a rare-event algorithmValérian Jacques-Dumas, Henk A Dijkstra
Current Opinion in Drug Discovery & Development|October 27, 2004
Recent developments in the discovery of protein kinase inhibitors from the urea classJacques Dumas, Roger A Smith, Timothy B Lowinger
Chaos (Woodbury, N.Y.)|December 19, 2024
Resilience of the Atlantic meridional overturning circulationValérian Jacques-Dumas, Henk A Dijkstra, Christian Kuehn
Current Topics in Medicinal Chemistry|July 18, 2006
Recent advances in the research and development of RAF kinase inhibitorsRoger A Smith, Jacques Dumas, Lila Adnane, et al.
Current Pharmaceutical Design|October 9, 2002
Design and discovery of small molecules targeting raf-1 kinaseTimothy B Lowinger, Bernd Riedl, Jacques Dumas, et al.
Medecine Sciences : M/S|January 7, 2020
[Developability assessment with case studies highlighting the decision taking]Jacques Dumas, Anne Sévérac, Cendrine Lemoine, et al.
The Science of the Total Environment|August 25, 2004
Sampling frequency and accuracy of SPM flux estimates in two contrasted drainage basinsAlexandra Coynel, Jörg Schäfer, Jean-Emmanuel Hurtrez, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Opinion in Drug Discovery & Development|March 13, 2003
Protein kinase inhibitors from the urea classJacques Dumas
Expert Opinion on Therapeutic Patents|February 10, 2010
VEGF receptor kinase inhibitors: phthalazines, anthranilamides and related structuresJacques Dumas, Julie A Dixon
Medecine Sciences : M/S|January 7, 2020
[Developability assessment]Jacques Dumas, Sylvain Huille, Catherine Prades
Chaos (Woodbury, N.Y.)|February 24, 2026
Quantification of the cascading tipping probability from the AMOC to the Amazon rainforest with a rare-event algorithmValérian Jacques-Dumas, Henk A Dijkstra
Current Opinion in Drug Discovery & Development|October 27, 2004
Recent developments in the discovery of protein kinase inhibitors from the urea classJacques Dumas, Roger A Smith, Timothy B Lowinger
Chaos (Woodbury, N.Y.)|December 19, 2024
Resilience of the Atlantic meridional overturning circulationValérian Jacques-Dumas, Henk A Dijkstra, Christian Kuehn
Current Topics in Medicinal Chemistry|July 18, 2006
Recent advances in the research and development of RAF kinase inhibitorsRoger A Smith, Jacques Dumas, Lila Adnane, et al.
Current Pharmaceutical Design|October 9, 2002
Design and discovery of small molecules targeting raf-1 kinaseTimothy B Lowinger, Bernd Riedl, Jacques Dumas, et al.
Medecine Sciences : M/S|January 7, 2020
[Developability assessment with case studies highlighting the decision taking]Jacques Dumas, Anne Sévérac, Cendrine Lemoine, et al.
The Science of the Total Environment|August 25, 2004
Sampling frequency and accuracy of SPM flux estimates in two contrasted drainage basinsAlexandra Coynel, Jörg Schäfer, Jean-Emmanuel Hurtrez, et al.
Pageof 3